Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

We conducted a systematic review and meta-analysis to summarize emerging data on the safety and effectiveness of dual biologic therapy in combination or with tofacitinib in patients with refractory inflammatory bowel disease (IBD).

Source: Clinical Gastroenterology and Hepatology - March 30, 2021 Category: Gastroenterology Authors: Waseem Ahmed, Jonathan Galati, Anand Kumar, Paul J. Christos, Randy Longman, Dana J. Lukin, Ellen Scherl, Robert Battat Source Type: research